Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Author: Benzinga Insights | August 08, 2023 09:06am

Gainers

  • Vivos Therapeutics (NASDAQ:VVOS) shares moved upwards by 102.7% to $0.53 during Tuesday's pre-market session. The company's market cap stands at $15.8 million.
  • Infinity Pharmaceuticals (NASDAQ:INFI) stock increased by 63.02% to $0.15. The company's market cap stands at $13.1 million.
  • Monopar Therapeutics (NASDAQ:MNPR) shares moved upwards by 16.54% to $0.88. The company's market cap stands at $11.6 million.
  • RxSight (NASDAQ:RXST) shares moved upwards by 16.15% to $33.5. The company's market cap stands at $1.1 billion. As per the news, the Q2 earnings report came out yesterday.
  • Hims & Hers Health (NYSE:HIMS) shares moved upwards by 15.06% to $9.09. The market value of their outstanding shares is at $1.9 billion. As per the news, the Q2 earnings report came out yesterday.
  • SILO Pharma (NASDAQ:SILO) stock rose 14.73% to $2.57. The market value of their outstanding shares is at $8.1 million.

Losers

  • Renovaro Biosciences (NASDAQ:RENB) stock decreased by 20.2% to $0.6 during Tuesday's pre-market session. The market value of their outstanding shares is at $38.2 million.
  • Vistagen Therapeutics (NASDAQ:VTGN) shares fell 16.33% to $10.92. The company's market cap stands at $87.1 million.
  • Maravai LifeSciences (NASDAQ:MRVI) shares declined by 12.89% to $9.6. The company's market cap stands at $1.2 billion. As per the press release, Q2 earnings came out yesterday.
  • ICU Medical (NASDAQ:ICUI) stock declined by 11.93% to $151.0. The market value of their outstanding shares is at $3.6 billion. As per the news, the Q2 earnings report came out yesterday.
  • Inogen (NASDAQ:INGN) stock decreased by 11.34% to $6.65. The market value of their outstanding shares is at $153.7 million. The company's, Q2 earnings came out yesterday.
  • Enveric Biosciences (NASDAQ:ENVB) shares declined by 10.47% to $2.48. The company's market cap stands at $5.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ENVB HIMS ICUI INFI INGN MNPR MRVI RENB RXST SILO VTGN VVOS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist